Kim JH, Yim J. Achievements in and Challenges of Tuberculosis Control in South Korea. 2015;21(11):1913–20.

WHO. Global Tuberculosis Report. 2013. 1689–1699 p.

Chamberlain PD, Sadaka A, Berry S. Ethambutol optic neuropathy. 2017;

Kim YJ. Natural Course and Prognostic Factors of Ethambutol Toxic Optic Neuropathy. :4–11.

Chen S, Lin M, Sheu S. Incidence and prognostic factor of ethambutol-related optic neuropathy : 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358–62.

Sari RI, Nusanti S, Siregar NC, Sidik M. The Effect of Citicoline on Ethambutol Optic Neuropathy: Histopathology & Immunohistochemistry analysis of Retina Ganglion Cell Damage Level in Rat Model.

Bandyopadhyay S, Banerjee S, Bandyopadhyay S, Shamantha M, Biswas S. A Prospective Evaluation of Ocular Toxicity in Patients Receiving Ethambutol as Anti ‑ tubercular Therapy. Sudan J Ophthalmol. 2020;12(1):10–4.

Sadun AA, Wang MY. Ethambutol optic neuropathy: How we can prevent 100,000 new cases of blindness each year. J Neuro-Ophthalmology. 2008;28(4):265–8.

Kim U, Hwang JM. Early stage ethambutol optic neuropathy: Retinal nerve fiber layer and optical coherence tomography. Eur J Ophthalmol. 2009;19(3):466–9.

Grahn BH, Paterson PG, Gottschall-Pass KT, Zhang Z. Zinc and the Eye. J Am Coll Nutr. 2001 Apr;20(2):106–18.

Sarkar S. Current Overview of Anti-Tuberculosis Drugs : Metabolism and Toxicities Mycobacterial Diseases Current Overview of Anti-Tuberculosis Drugs : Metabolism and Toxicities. 2017;(May).

Chung H, Hee Y, Jin J, Sook K, Young J, Kim J. Ethambutol-induced toxicity is mediated by zinc and lysosomal membrane permeabilization in cultured retinal cells ☆. Toxicol Appl Pharmacol. 2009;235(2):163–70.

Kinoshita J, Iwata N, Maejima T, Kimotsuki T. Retinal Function and Morphology in Monkeys with. 2012;7052–62.